30 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
26961283	10	In vitro and in silico PTP-1B inhibition and in vivo antidiabetic activity of semisynthetic moronic acid derivatives.	Universidad Aut£Noma Del Estado De Morelos
26191366	66	Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 Inhibitors.	Indiana University School of Medicine
25264584	20	Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.	Universidad Aut£Noma Del Estado De Morelos
25938987	49	Is RK-682 a promiscuous enzyme inhibitor? Synthesis and in vitro evaluation of protein tyrosine phosphatase inhibition of racemic RK-682 and analogues.	University of Campinas
25907364	29	A potent and selective inhibitor for the UBLCP1 proteasome phosphatase.	Indiana University
25003231	59	Therapeutic potential of targeting the oncogenic SHP2 phosphatase.	Indiana University School of Medicine
24287560	61	Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.	University of Messina
23713581	75	A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases.	Indiana University School of Medicine
23305444	171	Discovery and evaluation of novel inhibitors of mycobacterium protein tyrosine phosphatase B from the 6-Hydroxy-benzofuran-5-carboxylic acid scaffold.	Indiana University School of Medicine
21988196	15	Low molecular weight phosphotyrosine protein phosphatases as emerging targets for the design of novel therapeutic agents.	University of Messina
21341673	106	Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells.	University of Southern California
21453996	20	Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.	Universidad Aut£Noma Del Estado De Morelos
22381357	41	New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells.	University of Messina
17543532	46	5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases.	Universit£
21669525	18	Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening.	Indiana University
19889539	49	Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.	University of California
20170098	21	Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2).	Indiana University School of Medicine
19297174	41	Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.	University of Modena and R.E.
19217304	44	5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors.	University of Messina
16759857	59	Design and synthesis of potent, non-peptidic inhibitors of HPTPbeta.	Procter & Gamble Pharmaceuticals
32631543	1	SAR of non-hydrolysable analogs of pyridoxal 5'-phosphate against low molecular weight protein tyrosine phosphatase isoforms.	Saint John'S University
29155585	9	Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment.	Chinese Academy of Sciences
29116812	29	X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase Inhibitors.	Yale University
28017602	2	A Common Platform for Antibiotic Dereplication and Adjuvant Discovery.	Mcmaster University